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Asbestos is a family of crystalline-hydrated
silicates with a fibrous geometry, including
chrysotile [Mg6Si4O10(OH)8], the curly ser-
pentine-type, and crocidolite [Na2(Fe3+)2
(Fe2+)3Si8O22(OH)2], the rodlike amphibole-
type asbestos (Mossman et al. 1990; Mossman
and Gee 1989). Clinical and epidemiologic
studies have established that asbestos ﬁbers are
associated with the development of pulmonary
interstitial ﬁbrosis, lung cancer, and malignant
mesothelioma (Mossman et al. 1990; Mossman
and Gee 1989). Asbestos exposure induces
diverse cellular events related to lung injury
(Jaurand 1997; Kamp and Weitzman 1999;
Manning et al. 2002). However, the molecular
mechanisms of asbestos-induced ﬁbrogenesis
and carcinogenesis and of repair of lung injury
are not fully understood.
The p53 tumor suppressor protein plays
an important role in the control of genomic
integrity or the elimination of damaged or
tumorigenic cells (Bargonetti and Manfredi
2002; Levine 1997; Vousden 2000). The
mutational inactivation of p53 protein is one
of the most common genetic events that
occur in human cancers (Hupp et al. 2000).
It has been reported that the frequency of
p53 protein accumulation is increased in lung
carcinomas of patients with clinical or histo-
logic asbestos exposure (Nuorva et al. 1994).
Treatment with crocidolite increased the
number of p53 protein–expressing cells in
A549 human pulmonary epithelial cells
(Johnson et al. 1997; Johnson and Jaramillo
1997), and treatment with chrysotile induced
the elevation of p53 protein level in rat
pleural mesothelial cells (Levresse et al. 1997).
In addition, inhaled chrysotile induced the
expression of p53 protein at ﬁber deposition
sites (bronchiolar–alveolar duct bifurcations)
in rat lungs (Mishra et al. 1997). These ﬁnd-
ings suggest a possible association between
asbestos exposure and accumulation of p53
protein in the pulmonary tissues or cells.
The p53 protein is phosphorylated on
multiple residues in both the amino- and car-
boxy-terminal domains by several different
protein kinases (Giaccia and Kastan 1998;
Lakin and Jackson 1999; Meek 1998). Among
serine residues, phosphorylation at position 15
has been shown to play an important role in
the stabilization and subsequent induction and
transactivation function of p53 (Dumaz and
Meek 1999; Shieh et al. 1997; Siliciano et al.
1997). Members of the phosphatidylinositol
3-kinase–related kinase (PIKK) family such as
DNA-activated protein kinase (DNA-PK) and
ataxia-telangiectasia mutated (ATM) have
been implicated in the phosphorylation of
p53 at Ser15 (Giaccia and Kastan 1998; Lakin
and Jackson 1999; Meek 1998). Furthermore,
extracellular signal–regulated protein kinase
(ERK) and p38, the members of mitogen-
activated protein kinase (MAPK), have been
reported to induce p53 phosphorylation at
Ser15 (Bulavin et al. 1999; Kwon et al. 2002;
Persons et al. 2000; She et al. 2000, 2001;
Shih et al. 2001; Wang and Shi 2001).
In the present study, we examined whether
two different types of asbestos, chrysotile and
crocidolite, induce the phosphorylation of
p53 at Ser15 and other serines in A549
human pulmonary epithelial type II cells,
which express wild-type p53 (Jia et al. 1997).
Using inhibitors to the members of MAPK
and PIKK, we also determined the protein
kinases responsible for asbestos-induced p53
phosphorylation. Because reactive oxygen
species have been shown to be an important
mediator responsible for pulmonary toxicity
of asbestos (Kamp et al. 1992; Kamp and
Weitzman 1999; Quinlan et al. 1994), effects
of antioxidants such as catalase and N-acetyl-
cysteine on asbestos-induced p53 phosphory-
lation were also examined.
Materials and Methods
Preparation of asbestos fibers. Union
Internationale Contre le Cancer (UICC)
standard samples of Rhodesian chrysotile and
crocidolite asbestos were used in the present
study. The ﬁbers were suspended in distilled
water at the concentration of 1 mg/mL. Then
the suspensions were passed through a 22-
gauge needle eight times and sterilized by
autoclaving. Before the addition to the
medium, the ﬁbers were dispersed by sonica-
tion for 10 min and vortexed.
Cell culture and treatments. A549 cells
were obtained from Health Science Research
Resources Bank (Japan Health Sciences
Foundation, Osaka, Japan) and grown in
Earle’s minimum essential medium with
nonessential amino acids, 10% fetal bovine
serum, 100 U/mL penicillin, and 100 µg/mL
streptomycin (Gibco BRL, Life Technologies,
Inc., Rockville, MD, USA) in a humidified
atmosphere of 5% CO2, 95% air at 37°C.
For each experiment, exponentially growing
A549 cells were plated at 1.5 × 105 cells/well
in 12-well culture plates or 3 × 106 cells/dish
in 100-mm culture dishes, and cultured for 1
day before the experiments.
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We examined effects of asbestos exposure on the phosphorylation of p53 protein in human pul-
monary epithelial type II cells (A549), which express wild-type p53. In cells exposed to two different
types of asbestos, chrysotile (~1–6% iron content) and crocidolite (~27% iron content) ﬁbers, at the
doses of 1, 5, and 10 µg/cm2 for 24 hr, the levels of p53 phosphorylated at Ser15 and p53 protein
were correlated with the dose. On a per-weight basis, chrysotile was more potent in inducing Ser15
phosphorylation and accumulation of p53 protein than was crocidolite. After exposure to 10 µg/cm2
chrysotile, the levels of p53 phosphorylated at Ser15 and of p53 protein increased after 18 hr. Among
serines in p53 protein immunoprecipitated from A549 cells treated with chrysotile, only Ser15 was
markedly phosphorylated. In contrast, no clear phosphorylation was observed at Ser6, Ser9, Ser20,
Ser37, Ser46, or Ser392. Blocking of the extracellular signal–regulated protein kinase pathway with
U0126 or inhibition of p38 activity with SB203580 did not suppress chrysotile-induced Ser15 phos-
phorylation. On the other hand, treatment with wortmannin, an inhibitor of DNA-activated protein
kinase and ataxia–telangiectasia mutated, suppressed both chrysotile-induced Ser15 phosphorylation
and accumulation of p53 protein. Treatment with either catalase or N-acetylcysteine failed to suppress
chrysotile-induced Ser15 phosphorylation, suggesting that reactive oxygen species do not play a major
role in the phosphorylation of p53 protein. The present results show that asbestos, particularly
chrysotile, induces phosphorylation of p53 protein at Ser15 in A549 cells depending on a DNA dam-
age–signaling pathway. Key words: A549 cells, chrysotile, crocidolite, p53, phosphorylation, reactive
oxygen species, SB203580, Ser15, U0126, wortmannin. Environ Health Perspect 111:509–512
(2003). doi:10.1289/ehp.5945 available via http://dx.doi.org/ [Online 21 November 2002]
Research | ArticlesA549 cells were incubated with the com-
plete medium containing 1, 5, or 10 µg of
ﬁbers/cm2 of culture vessel for 24 hr. As a ref-
erence, 20 µM cadmium chloride (CdCl2;
Sigma Chemical Co., St. Louis, MO, USA),
which has been shown to induce the phospho-
rylation of p53 protein at Ser15 (Matsuoka
and Igisu 2001), was used. In the time course
study, A549 cells were incubated with 10 µg
of ﬁbers/cm2 for 3–24 hr. Untreated control
cells were incubated with the complete
medium alone and treated identically to the
cells exposed to asbestos.
U0126, SB203580, and wortmannin
(Calbiochem, La Jolla, CA, USA) were dis-
solved in dimethyl sulfoxide (DMSO).
Catalase (Calbiochem) was dissolved in dis-
tilled water. N-Acetylcysteine (Sigma) was
dissolved in phosphate-buffered saline (PBS)
immediately before use, and the pH was
adjusted to 7.4 with 2N NaOH. A549 cells
were preincubated with the complete medium
containing each compound for 30 min (for
wortmannin), 1 hr (for U0126, SB203580,
and catalase), or 12 hr (for N-acetylcysteine).
The control cells were preincubated with the
complete medium either alone or containing
DMSO at the concentration used in the
treated cells (0.05 or 0.08%). Then preincu-
bated and control cells were treated with or
without asbestos ﬁbers for 24 hr.
Western immunoblotting. After the incu-
bation with asbestos fibers or CdCl2, cells
were washed with PBS and lysed with sodium
dodecyl sulfate (SDS)–polyacrylamide gel
Laemmli sample buffer. Cell lysates were col-
lected, sonicated, and boiled for 5 min.
Aliquots equivalent to 2 × 105 cells were sub-
jected to SDS–polyacrylamide gel elec-
trophoresis on a 10% polyacrylamide gel and
transferred to a nitrocellulose membrane
(Hybond-ECL; Amersham Pharmacia
Biotech, Buckinghamshire, UK). The mem-
brane was blocked with 5% nonfat milk in
Tris-buffered saline containing 0.1% Tween 20
for 2 hr at room temperature. The antibodies
used were p53 (Pab 1801) antibody, actin (I-
19) antibody (Santa Cruz Biotechnology Inc.,
Santa Cruz, CA, USA), and phospho-p53
(Ser6, Ser9, Ser15, Ser20, Ser37, Ser46, and
Ser392) antibodies (Cell Signaling Technology,
Inc., Beverly, MA, USA). The membrane was
incubated overnight at 4°C with the primary
antibody diluted 1:100 (for p53 antibody) or
1:1,000 (for phospho-p53 antibodies). Protein
was detected with a Phototope-HRP Western
blot detection kit (Cell Signaling Technology).
After immunodetection, some blots were incu-
bated with Restore Western Blot Stripping
Buffer (Pierce Chemical Co., Rockford, IL,
USA) for 30 min at room temperature and
reprobed with actin antibody diluted 1:500 for
1 hr at room temperature.
Immunoprecipitation–Western immuno-
blotting. After the incubation with asbestos
ﬁbers, cells were washed with PBS and lysed in
RIPA buffer (PBS, 1% Nonidet P-40, 0.5%
sodium deoxycholate, 0.1% SDS) supple-
mented with 0.6 mM phenylmethylsulfonyl
ﬂuoride, 30 µL/mL aprotinin (Sigma A6279),
and 1 mM sodium orthovanadate. After soni-
cation, the lysates were stored on ice for 1 hr
and centrifuged at 10,000 × g for 10 min at
4°C. Then, cell lysates equivalent to 6 × 106
cells were incubated overnight at 4°C with 10
µg of p53 (Pab 1801) antibody agarose conju-
gate (Santa Cruz Biotechnology). The pellet
was washed four times with RIPA buffer and
suspended in SDS–polyacrylamide gel Laemmli
sample buffer. Phosphorylation of p53 protein
at Ser6, Ser9, Ser15, Ser20, Ser37, Ser46, and
Ser392 in the same samples was analyzed after
SDS–polyacrylamide gel electrophoresis and
immunoblotting with respective phospho-p53
antibodies. After stripping, the blots were
reprobed with p53 antibody.
Results
Accumulation of p53 phosphorylated at Ser15
and p53 protein by asbestos exposure. Exposure
to 20 µM CdCl2 for 24 hr induced a clear
phosphorylation of p53 at Ser15 and an
accumulation of p53 protein in A549 cells
(Figure 1), as has been shown in MCF-7
human breast cancer cells (Matsuoka and Igisu
2001). Similarly, in A549 cells exposed to
1–10 µg/cm2 of chrysotile or crocidolite for 24
hr, accumulation of both p53 phosphorylated
at Ser15 and p53 protein was found depending
on the dose (Figure 1). However, chrysotile
exposure induced more marked accumulation
of p53 phosphorylated at Ser15 and p53 pro-
tein than crocidolite exposure at each dose of
1, 5, and 10 µg/cm2. On the other hand, the
levels of actin were not changed by exposure to
chrysotile, crocidolite, or CdCl2 (Figure 1).
After exposure to 10 µg/cm2 chrysotile,
the levels of p53 phosphorylated at Ser15 and
p53 protein increased after 18 hr, whereas
actin levels were not changed after 3–24 hr
exposures (Figure 2). In A549 cells exposed to
10 µg/cm2 crocidolite, clear Ser15 phosphory-
lation was not found at 3–18 hr (data not
shown). Hereafter, we focused on p53 phos-
phorylation induced by exposure to 10
µg/cm2 chrysotile for 24 hr.
Phosphorylation of serine residues in p53
protein. We examined whether serine residues
other than position 15 in p53 protein can be
phosphorylated in response to chrysotile
exposure. In p53 protein immunoprecipitated
from A549 cells exposed to chrysotile, the
marked phosphorylation was found only at
Ser15 (Figure 3). On the other hand, clear
phosphorylation was not observed on Ser6,
Ser9, Ser20, Ser37, Ser46, or Ser392 in p53
immunoprecipitated, whereas equal amounts
of p53 protein were detected (Figure 3).
Effects of MAPK inhibitors on Ser15
phosphorylation in p53 protein. Treatment
with U0126 (5 and 20 µM), an inhibitor of
both activated and nonactivated forms of
MAPK/ERK kinase (MEK1/2) (Favata et al.
1998), or with SB203580 (5 and 20 µM), a
p38 inhibitor (Cuenda et al. 1995), did not
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Figure 1. Effects of chrysotile or crocidolite expo-
sure on the levels of p53 phosphorylated at Ser15
and p53 protein. A549 cells were incubated with
chrysotile (1, 5, or 10 µg/cm2), crocidolite (1, 5, or 10
µg/cm2), or CdCl2 (20 µM) for 24 hr. Cell lysates were
subjected to Western immunoblotting using phos-
pho-p53 (Ser15), p53, and actin antibodies. Results
shown are representative of three independent
experiments.
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Figure 2. Time course of chrysotile-induced accu-
mulation of p53 phosphorylated at Ser15 and p53
protein. A549 cells were incubated with 10 µg/cm2
chrysotile for 3–24 hr. The untreated control is 0 hr.
Cell lysates were subjected to Western immuno-
blotting using phospho-p53 (Ser15), p53, and actin
antibodies. Results shown are representative of
three independent experiments.
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Figure 3. Effects of chrysotile exposure on the phos-
phorylation of serines in p53 protein. Abbreviations:
IP, immunoprecipitation; Ab, antibody; IB, Western
immunoblotting. A549 cells were incubated with 10
µg/cm2 chrysotile for 24 hr, and cell lysates were
incubated with p53 antibody agarose conjugate.
Phosphorylation of p53 at Ser6, Ser9, Ser15, Ser20,
Ser37, Ser46, and Ser392 in the same samples was
analyzed after Western immunoblotting using
respective phospho-p53 antibodies. After stripping,
the blots were reprobed with p53 antibody. Results
shown are representative of three independent
experiments. 
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2suppress chrysotile-induced Ser15 phosphory-
lation (Figure 4A, B). Treatment with a
higher concentration of U0126 (50 µM) or
SB203580 (50 µM) also failed to suppress
chrysotile-induced Ser15 phosphorylation,
whereas phosphorylated forms of ERK or p38
were not detected in A549 cells treated with
each compound (data not shown).
Effects of wortmannin on Ser15 phospho-
rylation in p53 protein. Treatment with
wortmannin (1 and 5 µM), an inhibitor of
DNA-PK and ATM (Sarkaria et al. 1998),
suppressed chrysotile-induced Ser15 phos-
phorylation and accumulation of p53 protein
depending on the concentration (Figure 5).
The levels of actin were not affected by treat-
ment with wortmannin (Figure 5).
Effects of catalase and N-acetylcysteine on
Ser15 phosphorylation in p53 protein.
Treatment with catalase (1 and 5 KU/mL) or
N-acetylcysteine (1 and 5 mM) did not
suppress chrysotile-induced Ser15 phos-
phorylation (Figure 6A, B). In addition, accu-
mulation of p53 protein in A549 cells
exposed to chrysotile was not suppressed by
treatment with catalase or N-acetylcysteine
(data not shown).
Discussion
In A549 cells exposed to two different types
of asbestos, chrysotile and crocidolite, at the
doses of 1–10 µg/cm2 for 24 hr, the levels of
p53 phosphorylated at Ser15 and p53 protein
were found to be elevated. Among serines in
p53 protein immunoprecipitated from A549
cells treated with 10 µg/cm2 chrysotile for 24
hr, only Ser15 was markedly phosphorylated.
In contrast, no clear phosphorylation was
observed at other serine residues examined
(Ser6, Ser9, Ser20, Ser37, Ser46, and
Ser392). Ser15 has been identiﬁed as a site on
p53 protein phosphorylated in response to
DNA-damaging agents such as ionizing radia-
tion (Shieh et al. 1997; Siliciano et al. 1997),
ultraviolet radiation (She et al. 2000; Shieh et
al. 1997; Siliciano et al. 1997), camptothecin
(Shieh et al. 1997), cisplatin (Persons et al.
2000), chromium (Wang and Shi 2001), and
cadmium (Matsuoka and Igisu 2001). The
present study clearly showed for the ﬁrst time
that asbestos exposure induces phosphoryla-
tion of p53 protein at Ser15 in a human pul-
monary epithelial cell line. Phosphorylation
of p53 at Ser15 was shown to reduce the
binding of murine double minute 2 (MDM2)
(Shieh et al. 1997), an E3 ligase that targets
both p53 and itself for ubiquitination
(Vousden 2000). The level of p53 mRNA as
determined using reverse transcriptase–poly-
merase chain reaction analysis was not ele-
vated in A549 cells treated with chrysotile or
crocidolite at 10 µg/cm2 for 24 hr (data not
shown). Therefore, asbestos-induced Ser15
phosphorylation might be responsible for the
accumulation of p53 protein at least in part.
When two types of asbestos fibers were
compared in their potency to induce Ser15
phosphorylation and accumulation of p53
protein, chrysotile was more marked than was
crocidolite on a per-weight basis. In agree-
ment with our results, treatment with 10
µg/cm2 crocidolite for 24 or 48 hr induced
less significant increases in p53 protein level
than did treatment with chrysotile in rat
pleural mesothelial cells (Levresse et al. 1997).
When DNA breakage was determined using
the single-cell gel (Comet) assay, chrysotile
was reported to induce more abnormalities in
comet parameters than did crocidolite in rat
pleural mesothelial cells (Levresse et al. 2000).
If this is the case in human pulmonary epithe-
lial cells as well, a higher genotoxic potential
of chrysotile asbestos might underlie the
marked phosphorylation and accumulation of
p53 protein observed in the present study.
The MAPKs, including ERK, p38, and
c-Jun NH2-terminal kinase (JNK), are a fam-
ily of serine/threonine protein kinases that
transmit extracellular signals into the nucleus
(Schaeffer and Weber 1999). Exposure to
chrysotile has been reported to activate ERK
in rat pleural mesothelial cells in vitro (Zanella
et al. 1996) and mouse pulmonary epithelial
cells in vivo (Robledo et al. 2000), although its
effects on p38 and JNK are not known. On
the other hand, Ser15 phosphorylation
induced by various cellular stimuli such as
ultraviolet radiation (Bulavin et al. 1999; She
et al. 2000), cisplatin (Persons et al. 2000),
L-thyroxine (Shih et al. 2001), chromium
(Wang and Shi 2001), resveratrol (She et al.
2001), and 3-methylcholanthrene (Kwon et
al. 2002) has been reported to be mediated by
ERK and/or p38. However, in the present
study, treatment with neither U0126 nor
SB203580 suppressed chrysotile-induced
Ser15 phosphorylation, indicating it is
unlikely that ERK and p38 are responsible for
p53 phosphorylation at Ser15 in A549 cells
exposed to chrysotile.
In contrast to MAPK inhibitors, treatment
with wortmannin suppressed both chrysotile-
induced Ser15 phosphorylation and accumu-
lation of p53 protein. These results suggest
that chrysotile-induced Ser15 phosphorylation
is dependent on PIKK family such as DNA-
PK and ATM, and support the possible role of
Ser15 phosphorylation in the accumulation of
p53 protein. DNA-PK and ATM are activated
after cellular exposure to agents that induce
DNA double-strand breaks (DSBs) or other
discontinuities in DNA (Canman et al. 1994;
Gottlieb and Jackson 1993; Morozov et al.
1994). It has been reported that chrysotile
exposure at doses of 8 or 16 µg/cm2 for 24 hr
induced DNA DSBs in both wild-type and
DNA DSB repair–deficient mutant Chinese
hamster ovary cells (Okayasu et al. 1999).
Therefore, DNA damage induced by chrysotile
exposure might activate the signaling pathways
leading to PIKK activation, and resultant p53
activation might contribute to the protection
of cells from fatal genetic injury.
The iron associated with asbestos fibers
promotes the formation of hydroxyl radicals
via the modiﬁed Haber-Weiss (Fenton) reac-
tion (Kamp et al. 1992; Kamp and Weitzman
1999; Quinlan et al. 1994). Although
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Figure 4. Effects of U0126 (A) and SB203580 (B) on
chrysotile-induced phosphorylation of p53 at Ser15.
A549 cells were preincubated with DMSO (0.08%),
U0126 (5 or 20 µM), or SB203580 (5 or 20 µM) for 1
hr and then incubated without or with 10 µg/cm2
chrysotile for 24 hr. Cell lysates were subjected to
Western immunoblotting using phospho-p53
(Ser15) antibody. Results shown are representative
of three independent experiments.
Figure 5. Effects of wortmannin on chrysotile-
induced phosphorylation of p53 at Ser15. A549 cells
were preincubated with DMSO (0.05%) or wort-
mannin (1 or 5 µM) for 30 min and then incubated
without or with 10 µg/cm2 chrysotile for 24 hr. Cell
lysates were subjected to Western immunoblotting
using phospho-p53 (Ser15), p53 and actin anti-
bodies. Results shown are representative of three
independent experiments.
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Figure 6. Effects of catalase (A) or N-acetylcysteine
(NAC) (B) on chrysotile-induced phosphorylation of
p53 at Ser15. A549 cells were preincubated with
catalase (1 or 5 KU/mL) for 1 hr or N-acetylcysteine
(1 or 5 mM) for 12 hr and then incubated without or
with 10 µg/cm2 chrysotile for 24 hr. Cell lysates
were subjected to Western immunoblotting using
phospho-p53 (Ser15) antibody. Results shown are
representative of three independent experiments.
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51chrysotile contains only ~1–6% iron primarily
as a surface contaminant (Kamp et al. 1992;
Kamp and Weitzman 1999), this asbestos has
been reported to generate hydroxyl radical-like
species and cause DNA strand breaks in
human pulmonary epithelial-like WI-26 cells
(Kamp et al. 1995). However, treatment with
catalase or N-acetylcysteine failed to suppress
chrysotile-induced Ser15 phosphorylation in
the present study. Furthermore, treatment with
deferoxamine (1 and 5 mM), an iron chelator,
did not suppress chrysotile-induced Ser15
phosphorylation but induced Ser15 phospho-
rylation significantly even in the absence of
asbestos (data not shown). Consistent with
these results, crocidolite asbestos, which has a
high iron content (~27%) (Kamp et al. 1992;
Kamp and Weitzman 1999), induced less
marked Ser15 phosphorylation in A549 cells.
Thus, chrysotile-induced p53 phosphorylation
at Ser15 might be caused by mechanisms not
based on reactive oxygen species, such as the
direct physical interaction with cellular compo-
nents or the generation of reactive nitrogen
species (Tanaka et al. 1998).
The p53 protein plays a central role in the
control of cell cycle progression or apoptotic
cell death (Bargonetti and Manfredi 2002;
Levine 1997; Vousden 2000). Therefore, there
is a possibility that cell cycle arrest (Levresse et
al. 1997) and apoptosis (Aikoh et al. 1998;
Broaddus et al. 1996; Dopp et al. 1995;
Hamilton et al. 1996; Wu et al. 2000) found in
cells exposed to chrysotile might be caused by
an activated form of p53 protein. On the other
hand, in transgenic mice with reduced and
enhanced p53 functions specifically targeted
within the pulmonary epithelium, asbestos
exposure induced less and more severe ﬁbro-
genic lesions in the lung, respectively (Nelson et
al. 2001). These ﬁndings suggest that p53 pro-
tein in cells exposed to asbestos has the ﬁbrosis
progressive function as well as the tumor sup-
pressive function. In other words, activation of
p53 by asbestos exposure might intensify its
pulmonary toxicity further by forming a posi-
tive feedback loop. To clarify the functions of
asbestos-induced p53 activation in the pul-
monary cells, genes, and/or pathways that are
activated after phosphorylation of p53 at Ser15,
the critical event for its transactivation (Dumaz
and Meek 1999; Shieh et al. 1997; Siliciano et
al. 1997), should be investigated.
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